Reference
Choi YJ, et al. A 10-Year Nationwide Pharmacovigilance Assessment on Anti-Obesity Medications and Factors Associated with Serious Adverse Events FASEB Journal : 17 May 2022. Available from: URL: https://doi.org/10.1096/fasebj.2022.36.S1.R3296
Rights and permissions
About this article
Cite this article
Anti-obesity drug AEs more common with phentermine and liraglutide. Reactions Weekly 1907, 5 (2022). https://doi.org/10.1007/s40278-022-15264-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-15264-1